{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-411260","form_type":"8-K","ticker":"QNCX","cik":"0001662774","company_name":"Quince Therapeutics, Inc.","filed_at":"2026-10-02T11:30:27+00:00","discovered_at":"2026-10-02T11:35:00.304587+00:00","generated_at":"2026-10-12T14:31:04.583219+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Quince Therapeutics board overhaul: 3 directors to resign, 4 named pending Oct 6 vote","bullets":["Directors June Bray, David Lamond and Christopher Senner conditionally resigned effective two business days after the Oct 6, 2026 Special Meeting; no disagreement with the Company cited.","Board seats contingent on approval of three proposals: Series C conversion (>20% of shares outstanding), Minimum Price Proposal, and raising authorized shares from 250M to 275M.","Incoming directors: Catherine Bonuccelli (Class I; Audit, Comp), Leone Patterson (Class III; chair Audit & Comp), James Valentine (Class I; chair NomGov), Drayton Wise (Class II; NomGov).","Conversion Proposal may, together with certain management and board changes, result in a change of control under Nasdaq Listing Rule 5635(b).","Incoming directors' backgrounds: Bonuccelli ex-Bellus Health CMO; Patterson ex-CFO Zymeworks and Tenaya; Wise ex-CCO Insmed; Valentine director at Hyman, Phelps & McNamara."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-411260","json":"https://secwatch.observer/filing/0001193125-26-411260.json","markdown":"https://secwatch.observer/filing/0001193125-26-411260.md","text":"https://secwatch.observer/filing/0001193125-26-411260.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526411260/0001193125-26-411260-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526411260/d171747d8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:31:04.583219+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}